Since the first recognition of AIDS as a clinical syndrome in 1981, remarkable progress has been made in defining the causative agent (HIV, or human immunodeficiency virus) and in characterizing its molecular and biological properties. Considerably less is known, however, about the basic pathogenetic mechanisms by which HIV induces persistent and fatal disease. Elucidation of the pathogenesis of HIV is essential for the development of effective preventive and treatment measures against the virus. We propose to establish a Program of Excellence for Basic Research on AIDS (PEBRA) whose programmatic theme and overall objective will be the elucidation of molecular mechanisms underlying HIV replication and pathogenesis. The Birmingham PEBRA will consist of a coordinated and multidisciplinary research effort involving seven projects, each of which will examine distinct viral and cellular processes involved in HIV replication and pathogenesis. Both HIV- 1 and HIV-2 will be studied. Project #1 will identify and characterize molecular determinants of HIV-2 pathogenicity and will define the role of novel HIV-2 gene products in regulating viral replication. Project #2 will define sites and primary amino acid sequence requirements for HIV-1 envelope precursor cleavage and will characterize the cellular enzymes involved in this critical processing event. Project #3 will define the function and structural biology of the HIV-2 envelope glycoprotein. Project #4 will identify and characterize HIV-1 viral proteins responsible for early replication events. Project #5 will examine the molecular and biologic consequences of HIV-1 infection of human astrocytes and will examine cellular and autocrine events that alter astrocyte and HIV gene expression. Project #6 will examine the biology of newly-discovered subpopulations of human CD4 lymphocytes which are distinguished by cell surface antigens and relative stage of activation and will define the replicative activity of HIV in the cells. In parallel, the project will also examine the structure, function, and expression of the avian CD4 molecule as a novel approach for defining the evolution of CD4. Project #7 will define the level and pattern of HIV-1 replication in vivo in naturally-infected adult and pediatric populations and will define and characterize molecular determinants of HIV-1 replication and virulence in field isolates of the virus. These studies will thus define at a molecular level biologic processes critical to viral replication and virulence and will relate this basic information to the elucidation of disease pathogenesis and strategies for treatment and prevention. In this program project, emphasis has been placed on the development of research directions that are unified by the programmatic objectives, that draw upon the strengths and expertise of the respective program leaders, and that represent novel approaches to the elucidation of basic mechanisms of viral pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI027290-03
Application #
3091957
Study Section
Special Emphasis Panel (SRC (90))
Project Start
1988-09-01
Project End
1993-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wilson, J E; Aulabaugh, A; Caligan, B et al. (1996) Human immunodeficiency virus type-1 reverse transcriptase. Contribution of Met-184 to binding of nucleoside 5'-triphosphate. J Biol Chem 271:13656-62
Dubay, J W; Dubay, S R; Shin, H J et al. (1995) Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J Virol 69:4675-82
Spies, C P; Ritter Jr, G D; Mulligan, M J et al. (1994) Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol 68:585-91
Norris, J G; Tang, L P; Sparacio, S M et al. (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J Immunol 152:841-50
Clark, S J; Kelen, G D; Henrard, D R et al. (1994) Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients. J Infect Dis 170:194-7
Benveniste, E N (1994) Cytokine circuits in brain. Implications for AIDS dementia complex. Res Publ Assoc Res Nerv Ment Dis 72:71-88
Byrne, J A; Stankovic, A K; Cooper, M D (1994) A novel subpopulation of primed T cells in the human fetus. J Immunol 152:3098-106
Bray, M; Prasad, S; Dubay, J W et al. (1994) A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A 91:1256-60
Borrow, P; Lewicki, H; Hahn, B H et al. (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103-10
Piatak Jr, M; Saag, M S; Yang, L C et al. (1993) High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-54

Showing the most recent 10 out of 58 publications